|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cytori Therapeutics Inc.
| | | Phone: | (858) 458-0900 | Fax: | (858) 458-0994 | Year Established: | 1996 | Employees: | 77 | Ticker: | CYTX | Exchange: | NASDAQ | Main Contact: | Marc H. Hedrick, M.D., President & CEO | | Other Contacts: | Mark T. Marino, M.D., Senior VP & CMO Russ Havranek, VP, Global Marketing Cheri Rice, VP, Portfolio Management and Development Jeremy Hayden, General Counsel & VP of Business Development John Harris, VP & General Manager of Cell Therapy John K. Fraser, PhD, CSO Jeremy Hayden, General Counsel & VP Business Development Kenneth K. Kleinhenz, VP, Quality & Regulatory Affairs Tiago Girão, VP, Finance & CFO
| | Company Description | Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple “ischemic” conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori’s proprietary technologies and products, including the Celution® System product family. | |
|
|
|
|
|